Bleakley Financial Group, LLC

Position in JNJ — Johnson & Johnson

CIK 1936953 PARSIPPANY, NJ

Position in JNJ

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$36,146,788

+$3,911,508 QoQ

Shares Held

142,327

+7.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

#535

of 4,676 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bleakley Financial Group, LLC holds $192,517,114 across 15 Drug Manufacturers - General names. JNJ ranks #2 (18.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	45,004	$53,979,152
2	JNJ	Johnson & Johnson This page	142,327	$36,146,788
3	ABBV	AbbVie Inc.	92,109	$23,178,308
4	MRK	Merck & Co., Inc.	155,898	$20,032,893
5	AMGN	Amgen Inc	38,445	$13,921,703
6	AZN	Astrazeneca PLC	66,437	$12,597,783
7	NVS	Novartis AG	44,930	$7,041,429
8	SNY	Sanofi	159,361	$6,798,340

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,146,788	142,327	+7.9%	Shares	Sole	2026-08-05
2026-03-31	$32,235,280	131,874	+6.1%	Shares	Sole	2026-05-04
2025-12-31	$25,732,163	124,340	-7.8%	Shares	Sole	2026-02-09
2025-09-30	$25,008,893	134,877	+20.0%	Shares	Sole	2025-11-10
2025-06-30	$17,163,448	112,363	+1.4%	Shares	Sole	2025-07-30
2025-03-31	$18,378,388	110,820	+9.9%	Shares	Sole	2025-05-01
2024-12-31	$14,576,972	100,795	-6.9%	Shares	Sole	2025-01-27
2024-09-30	$17,551,746	108,304	+2.7%	Shares	Sole	2024-10-16
2024-06-30	$15,411,110	105,440	-5.3%	Shares	Sole	2024-08-12
2024-03-31	$17,614,931	111,353	-0.1%	Shares	Sole	2024-05-08
2023-12-31	$17,469,456	111,455	-1.2%	Shares	Sole	2024-01-25
2023-09-30	$17,566,263	112,785	-8.3%	Shares	Sole	2023-11-14
2023-06-30	$20,354,490	122,973	+10.1%	Shares	Sole	2023-08-14
2023-03-31	$17,307,300	111,660	-4.2%	Shares	Sole	2023-05-12
2022-12-31	$20,600,039	116,615	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.